BURLINGTON,
Mass., Nov. 14, 2024 /PRNewswire/ -- Azenta, Inc.
(Nasdaq: AZTA) today announced that Company management will
participate in Stephens Annual Investment Conference, on
Wednesday November 20, 2024, which
includes a presentation beginning at 1:00 pm
CT. The live webcast can be accessed through the Azenta
investor relations website at https://investors.azenta.com/events.
A replay of the webcast will be available following the event.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider
of life sciences solutions worldwide, enabling impactful
breakthroughs and therapies to market faster. Azenta provides a
full suite of reliable cold-chain sample management solutions and
multiomics services across areas such as drug development, clinical
research and advanced cell therapies for the industry's top
pharmaceutical, biotech, academic and healthcare institutions
globally. Our global team delivers and supports these products and
services through our industry-leading brands, including GENEWIZ,
FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B
Medical Systems.
Azenta is headquartered in Burlington, MA,
with operations in North
America, Europe and Asia. For more information,
please visit www.azenta.com.
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial, Planning & Analysis and Investor
Relations
ir@azenta.com
Sherry
Dinsmore
sherry.dinsmore@azenta.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-stephens-annual-investment-conference-302305307.html
SOURCE Azenta
